Vaginitis Clinical Trials

12 recruitingLast updated: May 13, 2026

There are 12 actively recruiting vaginitis clinical trials across 6 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 4. Top locations include Memphis, Tennessee, United States, Laguna Hills, California, United States, Birmingham, Alabama, United States. Updated daily from ClinicalTrials.gov.


Vaginitis Trials at a Glance

12 actively recruiting trials for vaginitis are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Memphis, Laguna Hills, and Birmingham. Lead sponsors running vaginitis studies include Stratpharma AG, Cisen Pharmaceutical CO., LTD., and Chung Shan Medical University.

Browse vaginitis trials by phase

Treatments under study

About Vaginitis Clinical Trials

Looking for clinical trials for Vaginitis? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Vaginitis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Vaginitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Phase 4

Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole

Trichomonas VaginitisBacterial Vaginitis
Tulane University1,200 enrolled4 locationsNCT06261840
Recruiting
Not Applicable

VALOR: Vaginal Atrophy & Long-term Observation of Recovery

Atrophic vaginitisGenitourinary Syndrome of MenopauseVaginal Atrophy+3 more
Stratpharma AG2,000 enrolled14 locationsNCT05953090
Recruiting
Not Applicable

Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)

Vulvovaginal Candidiasis (VVC)Yeast Vaginitis
Coologics, Inc55 enrolled10 locationsNCT06983041
Recruiting
Phase 4

ASSIST-VLA: Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser Therapy

Atrophic vaginitisGenitourinary Syndrome of Menopause (GSM)Vaginal Atrophy
Stratpharma AG10 enrolled1 locationNCT07346287
Recruiting
Not Applicable

Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions

Vulvar DiseasesVaginitis
University of Virginia91 enrolled1 locationNCT06070454
Recruiting
Phase 3

Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository

Vaginitis
Peking University Shenzhen Hospital50 enrolled1 locationNCT04574089
Recruiting
Not Applicable

Effect of Lactobacillus Johnsonii or White Pomegranate Extract on the Vaginal Health

Vaginitis BacterialInflammation, Ear
Chung Shan Medical University150 enrolled1 locationNCT06069531
Recruiting
Phase 2Phase 3

Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/Vulvovaginitis

Candidal Vulvovaginitis (ICD-10 Code: B37.3)Vulvovaginal Candidiasis (VVC)
AVVA Pharmaceuticals Ltd.264 enrolled7 locationsNCT06835361
Recruiting
Phase 2

A Study of the Efficacy and Safety of WXSH0102 in Treating VCC Patients

Vaginitis
Cisen Pharmaceutical CO., LTD.108 enrolled2 locationsNCT06771063
Recruiting
Not Applicable

Using Micro Electro Mechanical Systems to Detect the Air of Vaginal Discharge

Vaginal InfectionVaginitis
Taiwan Carbon Nano Technology Corporation120 enrolled2 locationsNCT05557318
Recruiting

Fractional CO2 laser for postmenopausal vaginal symptoms - a follow-up study

Atrophic vaginitisPostmenopausal vaginal symptoms
GRACE Unit - School of Women's and Children's Health, UNSW Sydney, Australia30 enrolled1 locationACTRN12621000361808
Recruiting

Physiotherapists prescribing medications to manage pain in emergency departments and outpatient clinics

Peripheral musculoskeletal injuries / conditions / symptoms: sprains, strains, suspected simple fractures, subacute and chronic tendinitis, tendinosis, tenosynovitis, bursitis, tenovaginitis (trigger finger, DeQuervain’s) and osteoarthritic arthritic joint diseaseMusculoskeletal pain of spinal origin
QEII Jubilee Hospital2,500 enrolled5 locationsACTRN12615000525583